AlphaYouBP
Schedule 13G filing
Baselake Partners, LP disclosed a 5.8% stake in Kiora Pharmaceuticals Inc (KPRX)
Baselake Partners, LP reported owning 5.8% of Kiora Pharmaceuticals Inc (KPRX) (257,500 shares) in a Schedule 13G filed Sep 17, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 17, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.